Heart failure is a growing concern in the United Kingdom, affecting nearly one million individuals. A significant challenge in its management is the adverse impact of heart failure medications on renal function, which often leads to hospitalisation. To address this, the RENAL-HF programme is pioneering a new approach by co-designing personalised kidney care pathways that integrate seamlessly into primary care settings.

Understanding the Need for Personalised Care

Heart failure patients frequently face complications due to impaired renal function, a side effect of many heart failure medications. Regular renal monitoring is crucial to mitigate these adverse effects and optimise drug dosing. The RENAL-HF programme aims to establish a care pathway that tailors renal function monitoring and intervention thresholds to individual needs, thereby enhancing patient outcomes.

Collaborative Development of Care Pathways

The RENAL-HF programme adopts a comprehensive, six-stage methodology, engaging healthcare professionals, patients, and carers in its development process:

1. Assessing Current Practices: Initial research focuses on understanding existing methods for optimising heart failure treatment while preserving kidney health.
2. Co-Designing the Pathway: Collaborators work together to design a care pathway, incorporating personalised renal monitoring and intervention guidelines.
3. Identifying Support Elements: The pathway's success is contingent on identifying key elements that support its implementation in primary care.
4. Creating Training Materials: Comprehensive training resources are developed to aid primary care practitioners in adopting the new pathway.
5. Testing Usability: A prototype of the care pathway is tested for usability to ensure it meets the practical needs of primary care settings.
6. Feasibility and Acceptability Study: The final stage involves a study to assess the pathway's feasibility and acceptability before a wider clinical trial.

Optimising Care for Heart Failure Patients

The ultimate goal of the RENAL-HF programme is to implement an algorithm-guided, individualised treatment plan that improves health outcomes for heart failure patients. By leveraging insights from primary care practices, practitioners, and patients, the programme seeks to refine and validate the care pathway, paving the way for its integration into routine care.

Conclusion

In an era where precision medicine is becoming increasingly critical, the RENAL-HF programme stands at the forefront of innovation in heart failure management. Its focus on co-design and personalisation not only promises to enhance patient care but also exemplifies the power of collaborative research in transforming healthcare practices.

As the RENAL-HF programme progresses, it aims to set a benchmark for future initiatives, demonstrating that by prioritising patient-specific needs and harnessing collective expertise, we can significantly improve the quality of life for those living with complex health conditions like heart failure.

Source: Personalising renal function monitoring and interventions in people living with heart failure: protocol for co-designing a care pathway in the RENAL-HF programme